Related Experiment Video
Updated: Dec 12, 2025
08:48
Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19
Published on: February 16, 2022
3.2K
SARS-CoV-2 serological testing changes disease management in a PCR-negative patient
Dacre Knight1, Joan Irizarry-Alvarado2
1Division of General Internal Medicine, Mayo Clinic Florida, Jacksonville, Florida, USA knight.dacre@mayo.edu.
BMJ Case Reports
|August 14, 2020
Summary
Diagnosing COVID-19 can be challenging, even with statistical methods. This case highlights how serological testing is crucial for accurate diagnosis and guiding isolation decisions in complex COVID-19 cases.
Area of Science:
- Infectious Diseases
- Medical Diagnostics
- Epidemiology
Background:
- The COVID-19 pandemic presented diagnostic challenges for healthcare providers globally.
- Accurate diagnosis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is essential for disease control.
- Bayes' theorem aids diagnostic probability but may leave residual uncertainty.
Observation:
- A specific patient case presented a diagnostic conundrum for COVID-19.
- Standard diagnostic methods were insufficient to resolve the diagnostic uncertainty.
- Thorough utilization of testing methods, especially serological assays, was required.
Findings:
- Serological testing provided critical data to clarify the diagnostic status.
- Diagnostic findings guided specific isolation recommendations for the patient.
- Effective application of serological results informed individual patient management.
Implications:
- Accurate COVID-19 diagnosis is fundamental for implementing effective isolation and quarantine measures.
- This case demonstrates the value of serological testing in managing diagnostic uncertainty.
- Findings offer a practical example for clinicians managing complex COVID-19 cases and limiting disease spread.
